People · Operator
Named in public records as an officer, director or promoter · active 2009–2017 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Resolys Bio, Inc. | — | Biotechnology | Series A | $10.0M | $361.5M | 2016 |
| Beech Tree Labs, Inc. | — | Biotechnology | Series A | $7.5M | $4.5M | 2009 |
John McMichael at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John McMichael on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeffrey A. Eckmann | 2 | 2 |
| Thomas A. Hatch | 2 | 2 |
| Chris Garabedian | 1 | 8 |
| John A. Ross | 1 | 2 |
| Richard A. Sandberg | 1 | 2 |
| William De Witt Ryan | 1 | 1 |
| H.W. I. McKay Belk | 1 | 1 |
| Robert I. Kramer | 1 | 1 |
| James A. Tobin | 1 | 1 |
| John I. Glasson | 1 | 1 |
| Sheridan C. Biggs | 1 | 1 |
| Arthur De Witt Ackerman | 1 | 1 |
| Thomas C. Hatch | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.